Gene Expression Profiling of Lichen Planus Reflects CXCL9+-Mediated Inflammation and Distinguishes this Disease from Atopic Dermatitis and Psoriasis

Badr, 2005, IFN{alpha} enhances human B-cell chemotaxis by modulating ligand-induced chemokine receptor signaling and internalization, Int Immunol, 17, 459, 10.1093/intimm/dxh227

Belperio, 2003, Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection, J Immunol, 171, 4844, 10.4049/jimmunol.171.9.4844

Bosio, 2002, Kinetics of gene expression profiling in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke, Carcinogenesis, 23, 741, 10.1093/carcin/23.5.741

Bovenschen, 2005, Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation, Br J Dermatol, 153, 72, 10.1111/j.1365-2133.2005.06538.x

Buss, 2005, Expression profiling using SAGE and cDNA arrays, 7

Crow, 2003, Interferon-alpha: a new target for therapy in systemic lupus erythematosus?, Arthritis Rheum, 48, 2396, 10.1002/art.11226

Eckert, 2004, S100 proteins in the epidermis, J Invest Dermatol, 123, 23, 10.1111/j.0022-202X.2004.22719.x

Eriksen, 2005, Increased sensitivity to interferon-alpha in psoriatic T cells, J Invest Dermatol, 125, 936, 10.1111/j.0022-202X.2005.23864.x

Fah, 1995, Expression of MxA protein in inflammatory dermatoses, J Histochem Cytochem, 43, 47, 10.1177/43.1.7822763

Farthing, 1992, Langerhans cell distribution and keratinocyte expression of HLADR in oral lichen planus, J Oral Pathol Med, 21, 451, 10.1111/j.1600-0714.1992.tb00973.x

Flier, 2001, Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation, J Pathol, 194, 398, 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S

Guillot, 2005, The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment, Br J Dermatol, 152, 690, 10.1111/j.1365-2133.2005.06512.x

Hoffjan, 2005, The genetics of atopic dermatitis: recent findings and future options, J Mol Med, 83, 682, 10.1007/s00109-005-0672-2

Ichikawa, 1997, Keratin and involucrin expression in discoid lupus erythematosus and lichen planus, Arch Dermatol Res, 289, 519, 10.1007/s004030050233

Ichimura, 2006, Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus, J Oral Pathol Med, 35, 167, 10.1111/j.1600-0714.2006.00402.x

Lee, 2006, Type I interferon as a target of treatment in SLE, Endocr Metab Immune Disord Drug Targets, 6, 323, 10.2174/187153006779025702

Martinsson, 2005, Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation, Exp Dermatol, 14, 161, 10.1111/j.0906-6705.2005.00239.x

Nomura, 2003, Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis, J Allergy Clin Immunol, 112, 1195, 10.1016/j.jaci.2003.08.049

Parlato, 2001, Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities, Blood, 98, 3022, 10.1182/blood.V98.10.3022

Pennartz, 2004, Purification of neuronal precursors from the adult mouse brain: comprehensive gene expression analysis provides new insights into the control of cell migration, differentiation, and homeostasis, Mol Cell Neurosci, 25, 692, 10.1016/j.mcn.2003.12.011

Pinto, 2003, Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis, J Eur Acad Dermatol Venereol, 17, 193, 10.1046/j.1468-3083.2003.00583.x

Quekenborn-Trinquet, 2005, Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity, Br J Dermatol, 152, 489, 10.1111/j.1365-2133.2005.06384.x

Saeed, 2003, TM4: a free, open-source system for microarray data management and analysis, Biotechniques, 34, 374, 10.2144/03342mt01

Santoro, 2004, Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus, Am J Clin Pathol, 121, 758, 10.1309/GHY8AL2D45P2R234

Santoro, 2005, Recruitment of dendritic cells in oral lichen planus, J Pathol, 205, 426, 10.1002/path.1699

Sharif, 2004, IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis, J Immunol, 172, 6476, 10.4049/jimmunol.172.10.6476

Spandau, 1998, MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions, J Invest Dermatol, 111, 1003, 10.1046/j.1523-1747.1998.00426.x

Sra, 2005, Molecular diagnosis of cutaneous diseases, Arch Dermatol, 141, 225, 10.1001/archderm.141.2.225

Sugerman, 2000, Autocytotoxic T-cell clones in lichen planus, Br J Dermatol, 142, 449, 10.1046/j.1365-2133.2000.03355.x

Sugiura, 2005, Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope, Br J Dermatol, 152, 146, 10.1111/j.1365-2133.2005.06352.x

Tensen, 1999, Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3), J Invest Dermatol, 112, 716, 10.1046/j.1523-1747.1999.00581.x

Wenzel, 2006, Type I Interferon associated cytotoxic inflammation in lichen planus, J Cutan Pathol, 33, 672, 10.1111/j.1600-0560.2006.00527.x

Wenzel, 2005, Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus, J Pathol, 205, 435, 10.1002/path.1721

Willis, 1998, Keratin 17 is expressed during the course of SLS-induced irritant contact dermatitis, but unlike keratin 16, the degree of expression is unrelated to the density of dividing keratinocytes, Contact Dermatitis, 39, 21, 10.1111/j.1600-0536.1998.tb05806.x